ALTOMEDIUM SIGNALFINANCIAL10-K

Alto reduced capital expenditures substantially while building inventory levels and improving its balance sheet position through debt reduction.

The company appears to be transitioning from a capital-intensive investment phase to a more conservative operating posture, as evidenced by the sharp reduction in capex spending. The simultaneous inventory build suggests either preparation for increased demand or potential supply chain management, while the debt reduction indicates disciplined capital allocation and balance sheet strengthening.

Comparing 2026-03-13 vs 2025-03-13View on EDGAR →
FINANCIAL ANALYSIS

Alto's financial position shows a measured improvement with total debt declining 15% and overall liabilities reduced by nearly 19%, though this came alongside a 34% decrease in cash reserves. The company substantially reduced capital expenditures while building inventory levels by nearly 24%, suggesting a shift toward working capital optimization rather than fixed asset expansion. The overall picture indicates disciplined capital management with a focus on balance sheet deleveraging, though the lower cash position warrants monitoring.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-58.5%
$11.1M$4.6M

Capex reduced 58.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-34%
$35.5M$23.4M

Cash declined 34% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Inventory
Balance Sheet
+23.6%
$49.9M$61.7M

Inventory built 23.6% — monitor whether demand supports this build or if write-downs may follow.

Total Liabilities
Balance Sheet
-18.6%
$176.4M$143.5M

Liabilities reduced 18.6% — deleveraging improves balance sheet strength and financial flexibility.

Total Debt
Balance Sheet
-15.1%
$99.7M$84.6M

Debt reduced 15.1% — deleveraging strengthens balance sheet and reduces financial risk.

LANGUAGE CHANGES
NEW — 2026-03-13
PRIOR — 2025-03-13
ADDED
As of March 12, 2026, there were 77,292,548 shares of the registrant s common stock, $0.001 par value per share, and 896 shares of the registrant s non-voting common stock, $0.001 par value per share, outstanding.
Market For Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Management s Discussion and Analysis of Financial Condition and Results of Operations.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
+7 more — sign up free →
REMOVED
As of March 12, 2025, there were 76,611,090 shares of the registrant s common stock, $0.001 par value per share, and 896 shares of the registrant s non-voting common stock, $0.001 par value per share, outstanding.
Market For Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 31 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 32 Item 7A.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 51 Item 9A.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 54 Item 13.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →